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doi:10.1016/j.jmii.2011.01.021Nocardiosis is a life-threatening infection that affects the lungs, skin, and central nervous
system, particularly in immune-compromised patients. We report a case of disseminated
nocardiosis with pneumonia, brain abscesses, meningitis, and thyroiditis, for an individual with
recent steroid therapy. Recovery was uneventful with a 4-month course of sulfamethoxazolee
trimethoprim.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Nocrdiae are aerobic, branching, filamentous, Gram-posi-
tive actinomycetes that are ubiquitous saprophytes. They
are important parts of the normal microflora of soils
worldwide. Nocardiosis can occur as a localized or
disseminated infection1 and is commonly introduced
through the respiratory tract. Nocardiosis occurs in many
animals, such as cats, dogs, swines, and guinea pigs.Infectious Diseases, Depart-
edical Center, 901 Junghua
710.
ei.org.tw (H.-J. Tang).
an Society of Microbiology. PublHowever, there is no evidence of respiratory spread from
infected animals to humans or of person-to-person spread.2
In immune-compromised patients, nocardiae are oppor-
tunistic pathogens. During the past three decades, 30e85%
of Nocardia infections involved immune-compromised
patients.1,5 The incidence of infection has increased recently,
probably related to the increasing numbers of moderately or
severely immune-compromised patients because of human
immunodeficiency virus infection or organ transplantation.
Other conditions that are notably associated with Nocardia
infection include lymphoreticular neoplasm, solid tumors,
chronic alcoholism, diabetic mellitus, systemic lupus eryth-
ematosus, chronic granulomatous disease, and intravenous
drug abuse.2,6 However, Nocardia infection can occur in
patients without concurrent disease or immunosuppressive
therapy.ished by Elsevier Taiwan LLC. All rights reserved.
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them are capable of causing diseases in humans.3 In humans,
the most frequently encountered species are Nocardia
asteroids complex (including its subtypes Nocardia nova and
Nocardia farcinica); Nocardiabrasiliensis; and Nocardia oti-
tidiscaviarum.4 Pulmonary infection occurs most frequently,
although extrapulmonary infections may occur, especially in
the central nervous system (CNS) and soft tissues. The
thyroid gland is a rare location for Nocardia infection.
Case report
A 70-year-old female retired farmer was hospitalized
because of a 3-day history of fever and chills. She had been
well until 1 month previously when she was admitted to
a medical center for treatment of chronic obstructive
pulmonary disease with secondary infection and acute
exacerbation. During the intervening time, she received
oral prednisolone (15 mg daily). Three days before the
current admission, she developed fever, chills, headache,
cough with yellow sputum, and nausea. No obvious wound
or history of animal contact was evident.
At admission, a chest X-ray showed an increased patchy
density over the left lower lung. Laboratory tests disclosed
leukocytosis (white blood count of 17,500). She was admitted
under an impression of chronic obstructive pulmonary disease
with pneumonia. Empirical antibiotics were used, including
beta-lactams [cefazolin (stazolin), amoxicillineclavulanate
(Augmentin), or ceftazidime (Fortum)] and gentamycin. Her
fever, headache, and cough persisted.
A brain computed tomography scan revealed edematous
foci in the bilateral cerebellar hemispheres and corona
radiata. A lumbar puncture was performed, and examination
of the cerebrospinal fluid (CSF) revealed erythrocytic
pleocytosis (4,300/mm3) and neutrophilic pleocytosis
(leukocytesZ 950/mm3 with 73% neutrophils). Normal open
and closing cardiac pressures of 65 mmH2O and 73 mmH2O,Figure 1. Brain MRI revealingmultiple high T2 nodular lesions of bil
TMPeSMX therapy. (B) After 4 months’ TMPeSMX therapy, regressio
infective foci over bilateral basal ganglia (arrow). MRIZmagnetic rerespectively,were noted.Gramandacid-fast stains of CSF did
not detect bacteria. A chest computed tomography scan
revealed a lobulate mass with central necrosis in the left
lingual segment and a nodular goiter in the right lobe of
the thyroid. Bacterial cultures of blood, CSF, and sputum
were sterile. Using sonography-guided aspiration, pus was
obtained, from which N asteroids was cultured. Thereafter,
trimethoprimesulfamethoxazole (TMPeSMX (Barktar);
15 mg/kg/d)was given.Thepatient’s history failed todisclose
any symptoms or signs related to thyroid disease. In addition,
no anterior neck trauma was noted.
Brain magnetic resonance imaging (Fig. 1A) disclosed
multiple infra- and supratentorial abscesses with basal
meningitis. Although the patient was lethargic initially, she
was well response to TMPeSMX therapy and regained normal
consciousness. She was discharged after a month of antibi-
otic treatment. Three months later, a second brain magnetic
resonance imaging confirmed resolution of the abscesses
(Fig. 1B), and a second chest X-ray showed the absence of
pulmonary infiltration. Follow-up sonography of the thyroid
revealed the absence of the abscess. Antimicrobial therapy
with TMPeSMX was maintained for 4 more months.
Discussion
Primary Nocardia infections that initially involve the lung,
skin, or soft tissue may invade into blood vessels and spread
hematogenously. The presence of lesions in two or more
organs defines systemic or disseminated disease, which is
characterized by widespread abscess formation. The
commonly reported sites include the CNS, eye (particularly
the retina), skin and subcutaneous tissues, kidneys, joints,
bones, and heart.2,6,7,9 The CNS is involved in about one-
third of the cases of disseminated nocardiosis.8 The most
common clinical manifestation of CNS nocardiosis is brain
abscess, most often presenting as multiloculated lesions;
this was noted in the present case. Meningitis occurs lessateral basal ganglia and cerebra. (A) Original MRI obtained before
n of brain abscesses was evident, with some remaining residual
sonance imaging; TMPeSMXZ trimethoprimesulfamethoxazole.
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Nocardia asteroids complex is the major causative path-
ogen of CNS nocardiosis.8
Clinical experience has shown that successful nocardio-
sis therapy requires the use of antimicrobial drugs in
combination with appropriate surgical debridement or
drainage, if necessary.4 Of note, antimicrobial drugs are
the mainstay of therapy. Because TMPeSMX has good
tissue penetration and is available in an oral form, it is the
drug of choice for most of the Nocardia infections.10,11
Other alternative antimicrobial drugs include imipenem,
amikacin, minocycline, quinolone, some third-generation
cephalosporins, or a ß-lactam/ß-lactamase inhibitor
combination.4,12
Clinical improvement is usually evident within 3e5
days,13 and at least 3 months’ therapy is generally recom-
mended. For compromised patients with disseminated or
CNS nocardiosis, 6e12 months or longer of such therapy
may be necessary.4,12 However, it is suggested that in vitro
susceptibility tests for Nocardia isolates should be done,
especially when the response to antimicrobial therapy is
poor or when Nocardia species are isolated. The rationale
for the latter is that N farcinica has a high degree of
resistance to cefotaxime, cefamandole, and tobramycin,
and N otitidiscaviarum has inconsistent susceptibility to
sulfonamides.4 Although our patient received a relatively
shorter course of antibiotic treatment than the recom-
mended duration, a good clinical response and radiological
resolution of brain abscesses resulted. This result may be,
at least in part, because of her minimally or moderately
immune-compromised condition resulting from short-term
steroid therapy.
The thyroid gland is often resistant to infection because
of its encapsulation, high iodide content, rich blood supply,
and extensive lymphatic drainage.14 More than two-thirds
of women and 50% of men with suppurative thyroiditis have
pre-existing thyroid diseases.15 Other risk factors include
congenital anomalies, especially pyriform sinus fistula,
immune suppression, old age, or debilitating illness.16
Suppurative thyroiditis is often characterized by fever;
local inflammatory signs; and symptoms of dysphagia,
dysphonia, or hoarseness. The painless thyroid abscess
noted in the present case was unusual.
This case indicated that nocardiae should be considered
as etiological pathogens of thyroiditis, and that the thyroidgland could become involved because of disseminated
nocardiosis.
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